vaccines
DomesticBiological Product
Recombinant Human Insulin Injection
通化东宝药业股份有限公司
Drug Information
| Generic name | 重组人胰岛素注射液 |
|---|---|
| Trade name | 甘舒霖R |
| English name | Recombinant Human Insulin Injection |
| Dosage form | Injection |
| Specification | 3ml/300IU/笔芯 |
| Category | Biological Product |
| Approval no. | 国药准字S20020092 |
| Drug code | 86903546000865 |
| Manufacturer | 通化东宝药业股份有限公司 |
| Production address | 吉林省通化县东宝新村 |
| Origin | Domestic |
| Approval date | 2020-08-17 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.
